USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: TRANSLATIONAL SCIENCES, INC.
City: Memphis
State: TN
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $300,000.00 1
SBIR Phase II $2,999,979.00 1
STTR Phase I $167,685.00 1
STTR Phase II $1,519,440.00 1

Award List:

Novel Methods for Dissolving Blood Clots

Award Year / Program / Phase: 2010 / STTR / Phase I
Agency: HHS
Research Institution: University Of Tennessee Health Sci Ctr
Principal Investigator: Guy L. Reed – 617-432-4992
Award Amount: $167,685.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death worldwide. Current therapies for cardiovascular disease are associated with partial success, restricted access, delays, possible neurotoxicity and other important limitations. Our goal is to develop a novel… More

Reducing Stroke by a Novel, Clot-dissolving Antibody

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul H. Kussie – 706-421-3355
Award Amount: $300,000.00
Abstract:
DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to the economy are 57.9 billion. The vast majority of acute ischemic strokes are caused by a thrombus… More

Reducing Stroke by a Novel, Clot-dissolving Antibody

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Paul H. Kussie – 901-274-4506
Award Amount: $2,999,979.00
Abstract:
DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to the economy are 57.9 billion. The vast majority of acute ischemic strokes are caused by a thrombus… More

Novel Methods for Dissolving Blood Clots

Award Year / Program / Phase: 2012 / STTR / Phase II
Agency: HHS
Research Institution: UNIVERSITY OF WISCONSIN SYSTEM
Principal Investigator: Guy L. Reed – 617-432-4992
Award Amount: $1,519,440.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Each year, as many as 2 million Americans develop venous thromboembolism (VTE). VTEs are blood clots in the legs (venous thrombosis) that may travel to the lungs (pulmonary embolism). It is estimated that 10-20% of VTEpatients die, and the annual direct costs are… More